|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.58 USD | -1.06% |
|
-0.46% | +99.54% |
| 12-09 | Goldman Sachs Adjusts Price Target on Amphenol to $165 From $157, Maintains Buy Rating | MT |
| 12-02 | Amphenol Insider Sold Shares Worth $11,360,232, According to a Recent SEC Filing | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.87 | 10.04 | 10.86 | 10.18 | 10.87 | |||||
Return on Total Capital | 11.44 | 12.92 | 13.92 | 12.95 | 13.67 | |||||
Return On Equity % | 24.15 | 26.71 | 28.45 | 25.07 | 26.71 | |||||
Return on Common Equity | 24.27 | 26.86 | 28.57 | 25.1 | 26.73 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.98 | 31.28 | 31.91 | 32.53 | 33.88 | |||||
SG&A Margin | 8.84 | 8.42 | 8.71 | 9.14 | 9.21 | |||||
EBITDA Margin % | 22.69 | 23.58 | 23.76 | 23.9 | 25.46 | |||||
EBITA Margin % | 19.68 | 20.73 | 21.28 | 21.34 | 22.71 | |||||
EBIT Margin % | 19.11 | 19.94 | 20.64 | 20.66 | 21.7 | |||||
Income From Continuing Operations Margin % | 14.11 | 14.53 | 15.18 | 15.5 | 16.04 | |||||
Net Income Margin % | 13.99 | 14.63 | 15.07 | 15.36 | 15.92 | |||||
Net Avail. For Common Margin % | 13.99 | 14.43 | 15.07 | 15.36 | 15.92 | |||||
Normalized Net Income Margin | 11.06 | 11.74 | 12.21 | 12.23 | 12.85 | |||||
Levered Free Cash Flow Margin | 10.9 | 7.39 | 12.16 | 13.19 | 10.75 | |||||
Unlevered Free Cash Flow Margin | 11.74 | 8.05 | 12.79 | 13.88 | 11.64 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.74 | 0.81 | 0.84 | 0.79 | 0.8 | |||||
Fixed Assets Turnover | 6.95 | 8.06 | 8.66 | 8.07 | 8.2 | |||||
Receivables Turnover (Average Receivables) | 4.66 | 4.94 | 4.96 | 4.78 | 5.15 | |||||
Inventory Turnover (Average Inventory) | 4.28 | 4.45 | 4.31 | 3.98 | 4.27 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.38 | 2.43 | 2.42 | 2.17 | 2.37 | |||||
Quick Ratio | 1.6 | 1.51 | 1.52 | 1.36 | 1.62 | |||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.63 | 0.81 | 0.8 | 0.69 | |||||
Days Sales Outstanding (Average Receivables) | 78.49 | 73.94 | 73.53 | 76.31 | 71 | |||||
Days Outstanding Inventory (Average Inventory) | 85.48 | 81.95 | 84.67 | 91.8 | 85.69 | |||||
Average Days Payable Outstanding | 59.75 | 56.15 | 54.39 | 56.82 | 55.55 | |||||
Cash Conversion Cycle (Average Days) | 104.22 | 99.73 | 103.81 | 111.29 | 101.14 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 75.12 | 79.18 | 68.67 | 55.08 | 73.86 | |||||
Total Debt / Total Capital | 42.9 | 44.19 | 40.71 | 35.52 | 42.48 | |||||
LT Debt/Equity | 69.65 | 78.01 | 67.43 | 49.79 | 68.69 | |||||
Long-Term Debt / Total Capital | 39.77 | 43.54 | 39.98 | 32.11 | 39.51 | |||||
Total Liabilities / Total Assets | 55.77 | 56.54 | 53.71 | 49.01 | 54.03 | |||||
EBIT / Interest Expense | 14.24 | 18.77 | 20.29 | 18.59 | 15.22 | |||||
EBITDA / Interest Expense | 17.76 | 23.22 | 24.3 | 22.42 | 18.58 | |||||
(EBITDA - Capex) / Interest Expense | 15.36 | 20.1 | 21.31 | 19.75 | 15.51 | |||||
Total Debt / EBITDA | 2 | 1.88 | 1.56 | 1.48 | 1.81 | |||||
Net Debt / EBITDA | 1.15 | 1.42 | 1.1 | 0.95 | 0.98 | |||||
Total Debt / (EBITDA - Capex) | 2.31 | 2.18 | 1.78 | 1.68 | 2.16 | |||||
Net Debt / (EBITDA - Capex) | 1.33 | 1.64 | 1.26 | 1.08 | 1.17 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.54 | 26.48 | 16.06 | -0.54 | 21.25 | |||||
Gross Profit, 1 Yr. Growth % | 1.84 | 27.69 | 18.41 | 1.39 | 26.29 | |||||
EBITDA, 1 Yr. Growth % | -0.03 | 31.41 | 16.95 | 0.05 | 29.16 | |||||
EBITA, 1 Yr. Growth % | -0.84 | 33.21 | 19.15 | -0.26 | 29.01 | |||||
EBIT, 1 Yr. Growth % | 0.21 | 31.98 | 20.16 | -0.46 | 27.33 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4.24 | 30.23 | 21.31 | 1.5 | 25.5 | |||||
Net Income, 1 Yr. Growth % | 4.19 | 32.19 | 19.58 | 1.35 | 25.73 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.07 | 34.17 | 20.72 | -0.39 | 27.42 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 4.27 | 28.06 | 21.91 | 1.63 | 23.87 | |||||
Accounts Receivable, 1 Yr. Growth % | 12.39 | 25.78 | 7.19 | -0.49 | 25.57 | |||||
Inventory, 1 Yr. Growth % | 11.61 | 29.54 | 10.53 | 3.51 | 17.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.97 | 11.04 | 5.18 | 8.19 | 29.7 | |||||
Total Assets, 1 Yr. Growth % | 13.98 | 19.07 | 4.41 | 7.83 | 29.73 | |||||
Tangible Book Value, 1 Yr. Growth % | -94.26 | 1.76K | -80.21 | -354.74 | -21.13 | |||||
Common Equity, 1 Yr. Growth % | 18.86 | 17.03 | 11.32 | 18.97 | 17.32 | |||||
Cash From Operations, 1 Yr. Growth % | 5.97 | -3.26 | 41.2 | 16.28 | 11.31 | |||||
Capital Expenditures, 1 Yr. Growth % | -6.17 | 30.2 | 6.49 | -2.87 | 78.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -6.02 | -14.23 | 90.92 | 7.88 | -1.18 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -5.73 | -13.21 | 84.35 | 7.92 | 1.66 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.33 | 22.12 | 27.56 | 4.94 | 29.41 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.39 | 14.99 | 21.16 | 7.44 | 9.82 | |||||
Gross Profit, 2 Yr. CAGR % | 0.17 | 14.03 | 22.96 | 9.57 | 13.16 | |||||
EBITDA, 2 Yr. CAGR % | -0.92 | 14.62 | 23.97 | 8.17 | 13.68 | |||||
EBITA, 2 Yr. CAGR % | -1.22 | 14.93 | 25.99 | 9.02 | 13.44 | |||||
EBIT, 2 Yr. CAGR % | -1.34 | 15 | 25.93 | 9.37 | 12.58 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -0.15 | 16.51 | 25.69 | 10.96 | 12.86 | |||||
Net Income, 2 Yr. CAGR % | -0.07 | 17.36 | 25.73 | 10.09 | 12.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | -1.78 | 15.87 | 27.27 | 9.66 | 12.66 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 0.78 | 15.55 | 24.95 | 11.31 | 12.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.36 | 18.9 | 16.12 | 3.28 | 11.78 | |||||
Inventory, 2 Yr. CAGR % | 8.86 | 20.24 | 19.66 | 6.96 | 10.27 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 20.85 | 8.98 | 8.07 | 6.68 | 18.46 | |||||
Total Assets, 2 Yr. CAGR % | 10.78 | 16.5 | 11.5 | 6.11 | 18.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | -69.61 | 3.34 | 91.89 | -29 | 41.74 | |||||
Common Equity, 2 Yr. CAGR % | 15.78 | 17.94 | 14.14 | 15.08 | 18.14 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.61 | 1.25 | 16.87 | 28.14 | 13.77 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.6 | 10.53 | 17.75 | 1.71 | 31.67 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 10.52 | -10.22 | 27.96 | 43.52 | 3.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 10.22 | -9.55 | 26.49 | 41.05 | 4.74 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.71 | 15.02 | 24.81 | 15.7 | 16.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.04 | 9.86 | 15.35 | 13.45 | 11.86 | |||||
Gross Profit, 3 Yr. CAGR % | 4.87 | 8.61 | 15.48 | 15.31 | 14.88 | |||||
EBITDA, 3 Yr. CAGR % | 5.89 | 8.86 | 15.39 | 15.42 | 14.76 | |||||
EBITA, 3 Yr. CAGR % | 4.93 | 9.13 | 16.32 | 16.55 | 15.31 | |||||
EBIT, 3 Yr. CAGR % | 5.07 | 8.71 | 16.7 | 16.44 | 15.05 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 22.46 | 9.1 | 18.09 | 17.05 | 15.61 | |||||
Net Income, 3 Yr. CAGR % | 22.76 | 9.7 | 18.1 | 17.01 | 15.07 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.34 | 8.98 | 17.47 | 17.29 | 15.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.81 | 9.25 | 17.63 | 16.64 | 15.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.88 | 11.06 | 14.86 | 10.29 | 10.23 | |||||
Inventory, 3 Yr. CAGR % | 9.72 | 15.36 | 16.91 | 14.01 | 10.36 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.12 | 17.48 | 7.7 | 8.11 | 13.86 | |||||
Total Assets, 3 Yr. CAGR % | 7.21 | 13.48 | 12.32 | 10.26 | 13.46 | |||||
Tangible Book Value, 3 Yr. CAGR % | -55.12 | 19.77 | -40.43 | 110.9 | -26.47 | |||||
Common Equity, 3 Yr. CAGR % | 10.51 | 16.2 | 15.69 | 15.73 | 15.82 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.64 | 11.44 | 13.12 | 16.68 | 22.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.9 | 5.08 | 9.17 | 10.43 | 22.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 9.61 | 1.56 | 15.45 | 20.89 | 26.73 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 9.47 | 1.78 | 14.68 | 19.97 | 26.46 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.11 | 13.01 | 19.06 | 17.8 | 20.1 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.08 | 11.59 | 12.48 | 8.89 | 13.1 | |||||
Gross Profit, 5 Yr. CAGR % | 8.41 | 10.77 | 11.76 | 9 | 14.54 | |||||
EBITDA, 5 Yr. CAGR % | 8.76 | 12.18 | 12.78 | 8.58 | 14.7 | |||||
EBITA, 5 Yr. CAGR % | 8.13 | 11.97 | 12.89 | 9.09 | 15.16 | |||||
EBIT, 5 Yr. CAGR % | 8.15 | 12.07 | 12.96 | 8.97 | 15.03 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.46 | 13.67 | 23.74 | 9.84 | 15.97 | |||||
Net Income, 5 Yr. CAGR % | 9.53 | 14.09 | 23.94 | 9.86 | 15.98 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.83 | 11.94 | 12.97 | 9.25 | 15.52 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.16 | 13.98 | 24.33 | 10.07 | 15.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.06 | 12.71 | 10.48 | 7.88 | 13.62 | |||||
Inventory, 5 Yr. CAGR % | 11.41 | 15.32 | 13.59 | 11.92 | 14.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 15.98 | 14.83 | 12.83 | 13.04 | 11.88 | |||||
Total Assets, 5 Yr. CAGR % | 10.57 | 11.55 | 8.91 | 10.47 | 14.67 | |||||
Tangible Book Value, 5 Yr. CAGR % | -30.56 | 11.7 | -19.75 | -2.83 | -15.74 | |||||
Common Equity, 5 Yr. CAGR % | 10.7 | 11.39 | 11.95 | 15.75 | 16.67 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.09 | 7.4 | 13.7 | 17.84 | 13.38 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.97 | 13.56 | 11.11 | 3.72 | 17.67 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 6.25 | 2.27 | 16.61 | 16.63 | 10.41 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.55 | 2.77 | 15.98 | 15.97 | 10.6 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.43 | 16.97 | 18.27 | 14.08 | 18.04 |
- Stock Market
- Equities
- APH Stock
- Financials Amphenol Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















